Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

UFS first to mechanise agricultural technique
2006-05-09

    

Small farmers from Thaba `Nchu were the biggest group attending the farmers day at the UFS Paradys experimental farm.  From the left are Mr David Motlhale (a small farmer from Thaba 'Nchu), Prof Leon van Rensburg (lecturer at the UFS Department of Soil, Crop and Climate Sciences and project leader), Mr Nhlonipho Nhlabatsi (Agricultural Research Council, Glen), Ms Meisie Mthethwa (small farmer from Bloemspruit).  In front is Mr Patrick Molatodi (chairperson of the Tswelopele Small Farmer Association).
 

 

Some of the participants of the farmers day at the UFS Paradys experimental farm were from the left Prof Leon van Rensburg (lecturer at the UFS Department of Soil, Crop and Climate Sciences and project leader, Mr Patrick Molatodi (chairperson of the Tswelopele Small Farmers Association) and Prof Herman van Schalkwyk (Dean: UFS Faculty of Natural and Agricultural Sciences).

UFS first tertiary institution in world to mechanise agricultural technique
The University of the Free State (UFS) is the first tertiary institution in the world to mechanise the in-field rain water harvesting technique on a commercial scale.

The technique was recently demonstrated to about 100 small farmers at the UFS Paradys experimental farm outside Bloemfontein. 

“With this technique rain water is channeled to the plant and in this way food security is increased.  The advantage of the technique for commercial farmers lies in the reduced cultivation of land.  Small farmers will benefit from this because they can now move out into the fields and away from farming in their back yards,” says Prof Leon van Rensburg, lecturer at the UFS Department of Soil, Crop and Climate Sciences and project leader.    

Rain water harvesting is an antique concept that was used by communities before the birth of Christ.  In South Africa the technique is mainly used in the plots of small farmers where they make surface structures by hand. 

"The technique is also used for the first time by the UFS on commercial scale by means of the cultivation of a summer crop on 100 ha at the Paradys experimental farm,” says Prof Leon van Rensburg,

Of the farmers who attended the farmers day most represented about 42 rural communities in the vicinity of Thaba ‘Nchu.  A group of seven from KwaZulu-Natal also attended the proceedings.  These small farmers can for example apply this technique successfully on the 250-300 ha communal land that is available in the Thaba ‘Nchu area. 

The project is funded by the UFS and the National Research Foundation (NRF) and the farmers’ day was funded by the Water Research Commission.   

Media release
Issued by: Lacea Loader
Media Representative
Tel:   (051) 401-2584
Cell:  083 645 2454
E-mail:  loaderl.stg@mail.uovs.ac.za
9 May 2006

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept